Bensen Daniel's Form 4 filing
Tyra Biosciences, Inc. (TYRA) · filed Jul 12, 2023
- Accession no.
- 0001209191-23-042114
- Filed
- Jul 12, 2023
- Trade date
- Jul 10-12, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $30.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bensen DanielCIK 0001880946 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 10, 2023 | Common Stock | MOption exerciseAcquired | +1,202 | $0.61 | +$733.22 | 529,183 | Direct | |
| Jul 10, 2023 | Common Stock | SSaleDisposed | −1,202 | $16.01F2 | −$19,244.02 | 527,981 | Direct | |
| Jul 11, 2023 | Common Stock | MOption exerciseAcquired | +500 | $0.61 | +$305 | 528,481 | Direct | |
| Jul 11, 2023 | Common Stock | SSaleDisposed | −500 | $16.02F3 | −$8,010 | 527,981 | Direct | |
| Jul 12, 2023 | Common Stock | MOption exerciseAcquired | +201 | $0.61 | +$122.61 | 528,182 | Direct | |
| Jul 12, 2023 | Common Stock | SSaleDisposed | −201 | $16.23F4 | −$3,262.23 | 527,981 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 10, 2023 | Common Stock | MOption exerciseDisposed | −1,202 | $0.00 | $0 | 140,711 | Direct | |
| Jul 11, 2023 | Common Stock | MOption exerciseDisposed | −500 | $0.00 | $0 | 140,211 | Direct | |
| Jul 11, 2023 | Common Stock | MOption exerciseDisposed | −201 | $0.00 | $0 | 140,010 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.12. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Referenced by the price of 1 transaction in Table I.
- F3
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.06. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Referenced by the price of 1 transaction in Table I.
- F4
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.07 to $16.39. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Referenced by the price of 1 transaction in Table I.